Search

Your search keyword '"Munakata, Wataru"' showing total 420 results

Search Constraints

Start Over You searched for: Author "Munakata, Wataru" Remove constraint Author: "Munakata, Wataru"
420 results on '"Munakata, Wataru"'

Search Results

4. Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

9. Usefulness of hematopoietic progenitor cell monitoring to predict autologous peripheral blood stem cell harvest timing: A single-center retrospective study

13. P1086: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING IN JAPANESE PATIENTS WITH RELAPSED/REFRACTORY INDOLENT B-CELL NON-HODGKIN’S LYMPHOMA: PRIMARY ANALYSIS OF THE PHASE 2 STUDY MIRAGE

14. P1520: PROGNOSTIC IMPACT OF FEBRILE NEUTROPENIA AND DOSE INTENSITY OF R-CHOP THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, A SUPPLEMENTARY ANALYSIS OF JCOG0601

18. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma

27. Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies

28. Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)

29. Variegated RHOA mutations in adult T-cell leukemia/lymphoma

32. Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment

39. Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers

43. Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia

44. The outcome of watchful waiting in patients with previously treated follicular lymphoma

45. A Case of Diffuse Large B-cell Lymphoma with Portal Vein, Splenic Vein, and Superior Mesenteric Vein Tumor Embolization Diagnosed by Percutaneous Transhepatic Portal Vein Biopsy

47. Two -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemiatwo -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemia

49. Diagnostic utility and prognostic significance of the Ki‐67 labeling index in diffuse large B‐cell lymphoma transformed from follicular lymphoma: a study of 76 patients

Catalog

Books, media, physical & digital resources